During the past decade, Minnesota Clinical Study Center conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 45 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 24 clinical trials were completed. i.e. 92.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Minnesota Clinical Study Center" #1 sponsor was "Galderma R&D" with 8 trials, followed by "DUSA Pharmaceuticals, Inc." with 6 trials sponsored, "Stiefel, a GSK Company" with 6 trials sponsored, "Palvella Therapeutics, Inc." with 5 trials sponsored and "Amgen" with 5 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Minnesota Clinical Study Center" #1 collaborator was "GlaxoSmithKline" with 6 trials as a collaborator, "Athenex, Inc." with 2 trials as a collaborator, "Cosmeta Corp, A Gel-Del Technologies Company" with 1 trials as a collaborator, "Johnson & Johnson Consumer and Personal Products Worldwide" with 1 trials as a collaborator and "Novella Clinical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Minnesota Clinical Study Center" are "Acne Vulgaris" (19 trials), "Psoriasis" (18 trials), "Actinic Keratosis" (10 trials), "Plaque Psoriasis" (9 trials) and "Atopic Dermatitis" (7 trials). Many other conditions were trialed in "Minnesota Clinical Study Center" in a lesser frequency.

Most popular intervention types in "Minnesota Clinical Study Center" are "Drug" (113 trials), "Other" (11 trials), "Device" (7 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Vehicle" (18 trials), "PTX-022" (4 trials), "Vehicle Foam" (4 trials) and "CP-690,550" (3 trials). Other intervention names were less common.

The vast majority of trials in "Minnesota Clinical Study Center" are 115 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Minnesota Clinical Study Center". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 96 completed trials in Minnesota Clinical Study Center, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Minnesota Clinical Study Center, 2 "Phase 1" clinical trials were conducted, 58 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".